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Abstract.  Whey acidic protein (WAP) is an abundant 
rodent milk protein.  Its expression in mouse mammary 
epithelial cell cultures was previously found to require 
the formation of an extracellular matrix (ECM)-in- 
duced three-dimensional alveolar structure. In the ab- 
sence of such structures, cells were shown to secrete 
diffusible factors leading to suppression of WAP ex- 
pression.  We demonstrate here that (a) TGF-c~ produc- 
tion and secretion by mammary cells is downregulated 
by the basement membrane-dependent alveolar struc- 
ture, and (b) compared with/3-casein, WAP expression 
is preferentially inhibited both in culture and in trans- 
genic mice when TGF-ot is added or overexpressed. 
Thus, (c) the enhanced TGF-a production when cells 
are not in three-dimensional structures largely ac- 
counts for the WAP-inhibitory activity found in the 
conditioned medium. Since this activity can be abol- 
ished by incubating the conditioned medium with a 
function blocking antibody to TGF-tx.  The data sug- 
gest that ECM upregulates WAP by downregulating 
TGF-ct production. We also propose that changes in 
TGF-ct activity during mouse gestation and lactation 
could contribute to the pattern of temporal expression 
of WAP in the gland. These results provide a clear ex- 
ample of cooperation among lactogenic hormones, 
ECM, and locally acting growth factors in regulation 
of tissue-specific gene expression. 
W 
'I-IEY acidic protein (WAP) ~ is a highly abundant, 
major whey protein in rodent milk (Piletz et al., 
1981; Hennighausen et al., 1982).  The expression 
of the protein is used as a molecular marker for mammary 
gland differentiation, and its promoter has been used widely 
to permit tissue-specific expression of heterologous genes in 
the mammary gland of the rodents.  In mouse mammary 
gland, WAP mRNA can be detected by Northern analysis be- 
ginning from day 14 of pregnancy, reaching the highest level 
during lactation (Pittius et al., 1988a,b). This temporal ex- 
pression differs from the other better-studied milk proteins 
such as/3-casein, whose expression in the gland begins on 
day 8 of gestation or even earlier. Despite its abundance and 
the wide usage of its promoter, little is known about the regu- 
lation of WAP and the reason behind the remarkable differ- 
ence in the time course of WAP and/3-casein expression. 
Previous  work performed in  our  laboratory  showed a 
novel regulation of WAP gene expression in cultures of pri- 
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mary mouse mammary epithelial cells by extracellular ma- 
trix (ECM; Chen and Bissell, 1989). It was found that WAP 
expression had an absolute requirement for the formation of 
three-dimensional alveolar structures, achieved by culturing 
cells on a reconstituted-basement membrane (Li et al., 1987; 
Barcellos-Hoff et al.,  1989).  When formation of alveolar 
structures was prevented by culturing the cells on plastic, 
type I  collagen gel, floating collagen gel, or fixed Engel- 
breth-Holm-Swarm  (EHS)  matrices  (the  latter two allow 
/3-casein expression),  WAP was not expressed.  Diffusible 
factors in the conditioned medium of these cultures were 
shown to be responsible for inhibition of WAP expression. 
We postulated that WAP is negatively regulated by one or 
more secreted factors. It followed that a three dimensional 
structure with a central lumen, enclosed by a polarized epi- 
thelium layer and surrounded by basement membrane, sup- 
pressed either the expression of the inhibitor(s) or the access 
to the putative receptors, or both. 
Work previously performed in several laboratories has in- 
dicated that TGF-/5 and EGF, when added to mammary epi- 
thelial cell cultures, inhibit/3-casein synthesis (Taketani and 
Oka,  1983a,b; Mieth et al.,  1990;  Chen and Bissell,  1989 
and unpublished data).  Such inhibitory activity of TGF-/3 
was also demonstrated in mouse mammary explant cultures 
(Robinson et al., 1993), as well as in transgenic mice (Jhap- 
pan et al.,  1993).  In collaboration with Derynck's labora- 
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the transcription of  TGF-~I mRNA and protein in mammary 
epithelial cells (Streuli et al., 1993). It was found that when 
a mammary epithelial cell strain, CID-9, was cultured either 
on EHS or floating collagen I gel, TGF-~I promoter activity 
was dramatically suppressed. In addition, ~-casein was ex- 
pressed in floating collagen and EHS cultures, but not in at- 
tached collagen gel or plastic cultures where TGF-~I activity 
was relatively high. We therefore proposed that TGF-/$1 is 
an ECM-modulated/3-casein inhibitor (Streuli et al., 1993). 
As discussed above, however, WAP is not expressed on float- 
ing collagen gel (Chen and Bissell, 1989). Thus a downregu- 
lation of TGF-~I activity, and the presence of an endogenous 
basement membrane in floating collagen cultures (Streuli 
and Bissell,  1990),  is not sufficient to allow WAP expres- 
sion.  Since  EGF  and  TGF-ot  share  the  same  receptor 
(Derynck, 1988), and TGF-ot has been shown to be produced 
at high levels in human mammary cells (Zajchowski et al., 
1988),  we examined the possible inhibitory role of TGF-c~ 
for WAP expression in mouse mammary epithelial cells. 
Here, we identify TGF-c~ as the major mediator of ECM- 
regulation of WAP expression. We show that production of 
TGF-ot by mouse mammary epithelial cells is indeed culture 
substratum-dependent.  We  further  show  that TGF-c~ ac- 
counts for most, if not all, of the WAP inhibitory activities 
present in the conditioned medium of the cells cultured on 
plastic dishes. The significance of these findings in cell cul- 
ture is strengthened by demonstrating that WAP gene expres- 
sion is largely inhibited in the mammary gland of MMTV- 
TGF-ot transgenic mice. We therefore propose that ECM up 
regulates WAP expression via downregulation of TGF-ot in 
culture, and that temporal WAP expression in vivo may be 
directly related to the level of activity of this growth factor 
and the availability of its receptor. 
Materials and Methods 
Substrata, Growth Factors, and Antibodies 
EHS matrix was prepared by urea extraction at 4°C from EHS tumors pas- 
saged in C57BL mice (Kleinman et al., 1982).  This material was stored for 
up to 4 wk at 0°C. Each preparation contained 5-10 rag protein per ml, and 
was routinely assayed for activity and absence of  protein degradation on 5% 
reducing SDS-PAGE followed by silver staining. One milliliter or one hun- 
dred fifty microliter of EHS was plated on a 96-mm or 35-mm tissue culture 
dish (Falcon, Lincoln Park, NJ),  respectively. In [3H]thymidine-labeling 
experiments, coverslips were placed in 35-mm culture dishes before EHS 
was carefully spread onto both the dish and the coverslips. Synthetic mouse 
EGF was purchased from Sigma  Chem. Co. (St. Louis, MO). Recombinant 
human TGF-c~  and monoclonal anti-human TGF-c~ antibody were generous 
gifts from Rik Derynek (Department of Growth and Development, UCSF). 
Polyclonal sheep anti-rat TGF-c~ antibody was prepared and characterized 
as previously described (Russell et al.,  1993). 
Cell Culture 
Primary mouse mammary epithelial (PMME) cells were isolated from 15-d 
timed-pregnant CD-1  mice  (Charles  Rivers  Laboratories,  Wilmington, 
MA), as previously described (Emerman et al.,  1977;  Lee et al.,  1984; 
Barcellos-Hoff et al.,  1989).  They were cultured on various culture sub- 
strata in FI2 medium (GIBCO BRL, Gaithershurg, MD) containing lacto- 
genic hormones (5 ~,g/mi of insulin [Sigma],  1 ~g/ml of hydrocortisone 
(Sigma) and 3/tg/ml of prolactin [NIH]). For the first 40 h after plating, 
1 mg/ml fetuin (Sigma Chem. Co.) and 10%  FCS (Sigma) were also in- 
cluded in the medium. The initial plating density was 2  x  107 cells/100- 
mm dish and 2  x  106/35-mm dish, with a plating efficiency of "~50%. The 
initial serum-containing medium was replaced after 40 h by a differentiation 
medium, which was F12 plus only the three lactogenlc hormones. There- 
after, the medium was changed every other day. For inhibition studies, cells 
were cultivated in differentiation medium on EHS substratum for at least 
24 h after the removal of serum. They were then incubated with either the 
conditioned medium from plastic or the growth factors for 48 h before RNA 
was extracted. 
The CID-9 cell line (Schmidhauser et al., 1990) was derived by an en- 
richment of the epithelial population from COMMA-l-D, a nontransformad 
mouse manLroary cell strain (Danielson et al., 1984).  This enrichment pro- 
cess increased by more than fivefold the percentage of cells that could ex- 
press/3-casein as the result of ECM and lactogenic hormone treatment. 
CID-9 cells were maintained in growth medium (DMEM/F12 from Gibco, 
5% FCS, 5 t~g/mi of insulin, and 10/tg/mi gentamycin [UCSF]). Atthe on- 
set of experiments, cells were plated on various substrata in differentiation 
medium (DMEM/F12, lactngenlc hormones with 2% FCS for the first day 
of plating, and then in 0%  serum for the following 6 d). 
pl-l]Thymidine-labeling of PMME Cells 
and Autoradiography 
PMME cells were isolated from day-15-pregnant CD4 mice as described 
previously (Emermnn et  al.,  1977;  Lee et al.,  1984).  Cells (2  x  10  ~ 
cells/35-mm dish) were plated on EHS-precoated coverslips which were 
placed in 35-mm tissue culture dishes. The cells were cultured on the cover- 
slips in the presence of lactogenic hormones. On day 4 of culturing, two 
dishes with identical morphologies  were selected. One was then treated with 
40 ng/ml of TGF-c~ included in the differentiation medium,  and the other 
was fed only with the differentiation medium for 48 h. During the last 24 h, 
[3H]thymidine (10/~Ci/ml, 67 Ci/mmol) was added to both dishes. At the 
end of 6 d, the cells were fixed with methanol-acetone (1 vol:l vol), stained 
with di-amino-phenyl-indote  (DAPI, Sigma), and air dried before they were 
coated with Kodak NTB2 emulsion. They were developed overnight and 
thymidine-labeled nuclei were visualized and photographed under bright 
field microscopy. 
RNA Preparation and Northern Analysis 
Total RNA from cultured cells was prepared as described by Chomczynski 
and Sacchi (1987),  and RNA extraction from the gland was done according 
to the method described by Talhouk et al. (1992). Three micrograms of  each 
sample was resolved by electrophoresis on a 1% egarose gel. RNA was then 
transferred onto nylon filters (Hybond-N). 32p-labeled  WAP or E-casein 
cDNAs were used to probe the Northern blots. WAP cDNA insert (a gift 
from Lother Hennlghansen, NIH) was excised with restriction enzymes and 
gel-purified from a plasmid. ~-casein cDNA insert was a gift from Jeffrey 
Rosen (Baylor College of Medicine, Houston, TX). Hybridization of the 
filters with a probe for 28-s ribosomal RNA was often used as a control for 
RNA quality and even loading. Where quantification is indicated, bands 
with intensities falling within the linear range of the autoradiograpby were 
scanned and analyzed by densitometry. 
Metabolic 35  S-Laheling 
PMME cells which had been cultured for 5 d were methionine-starved for 
1 h before 35S-labeled  methionlne (ICN Biomedicals, Costa Mesa, CA) 
was added at 350/~Ci/mi (specific activity; 1,152 Ci/mmol). One milliliter 
of F12 differentiation medium (see description in cell culture) was added 
to each 35-ram dish and the cells were labeled for 16 h. 
For labeling the gland, the inguinal mammary glands were dissected out 
from timed-pregnant CD-I mice at different stages of gestation. One or two 
glands from each animal were cut with scissors into small pieces of "~ 2 mm 
in diameter before they were incubated in 4 ml of FI2 medium that con- 
tained 250/zCi/ml of [3SS]methionine  (ICN Biochemicals, Costa Mesa, 
CA) and lactogenic hormones. The mixture was then incubated in a hu- 
midified incubator with gentle rocking for 5 h. 
Lysate Preparation and Quantification 
Conditioned media were collected from cells in culture. After removal of 
cell debris by centrifngation, they were stored at -70°C. Cells were then 
lysed in radioimmune precipitation buffer (RIPA, 50 mM Tris-HCI, pH 7.4, 
150 mM NaC1, 5 mM Na2EDTA,  2 mM PMSF, 5/~g/ml aprotinin, 0.1% 
SDS, 0.2% NP-40, and 0.5% sodium deoxycholate). After homogenization 
by sonication and removal of cell debris by centrifugation, the lysates were 
stored at  -70°C. 
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[35S]methionine  were added on top of a  0.45-ttm filter unit to separate 
them from  the labeling  medium. The organoids were  then rinsed with  cold 
F12 medium before being frozen in liquid nitrogen. RIPA buffer was added 
to the frozen tissue pieces before they were subjected to homogenization. 
The homogenate was spun three times in the microfuge to get rid of tissue 
debris. Subsequently, the supernatant was stored at -70"C. Total incorpo- 
ration of radioactivity was calculated from the "lUA-precipitable counts 
contained in the aliquots taken from each lysate. Various amount of TCA- 
precipitable counts were used for immtmoprecipitation with different anti- 
bodies. 
Immunoprecipitations 
7.1.  with  WAP Antiserum.  (A  generous gift from Floyd Schanbacher, 
OSU.) At least 2  x  107 TCA-precipitable counts from each lysate were 
used to incubate with rabbit anti-mouse WAP antiserum for 2  h on ice. 
Thirty five microliter of Protein A-Sepharose (Sigma, 10% wt/vol in RIPA) 
was added to each sample, which was diluted with RIPA in a final volume 
of 500 ~1. After 45 rain of  gentle shaking in 4"C, the antibody-antigen com- 
plex was precipitated by centrifugation. The Sepharose beads were then 
washed three times with ice cold RIPA buffer and once with 50 mM TrisCl 
(pH 7.4),  and stored at  -70"C. 
7.2.  with TGF-a Antiserum.  From each cell lysate, at least 5  x  106 
TCA-precipitable counts  were  used  to  incubate  with polyclonal  sheep 
anti-rat TGF-a antibody for 2 h on ice. Secondary antibody against sheep 
IgGs (Zymed Labs., South San Francisco, CA) was then added followed by 
0.1 vol of 20% (wt/vol) protein A-Sepharose beads (Sigma). The antigen- 
antibody complex was pelleted and the Sepharose beads were washed as de- 
scribed  above. 
For TGF-a immunoprecipitation  of the conditioned medium, at least 
I0  6 TCA-prccipitable counts were used for each sample. To confirm that 
the immunoprecipitated  proteins were indeed  TGF-a-related,  a second set 
of the same samples were treated with "I'GF-~  antiserum which had been 
preincubated with excessive amounts (1 gg/ml) of synthetic rat TGF-a 
(Peninsula Laboratories  Inc., Belmont,  CA). The precipitation  procedure, 
after the addition of the secondary  antibody,  was carried out as previously 
described (Cheng et al., 1993). 
Gel Electrophoresis  and Autoradiography 
All the immunoprecipitated proteins were separated on a denaturing poly- 
acrylamide gel  (20%  acrylamidc/0.5%  bis-acrylamide) containing  10% 
(vol/vol) glycerol (Giulian et al.,  1985).  After electrophoresis, gels were 
fixed in a  solution with 50%  methanol and  10%  acetic acid, washed in 
ddH:O  for 30  rain,  and  treated  with gel  amplifier (Amersham Corp., 
Arlington Heights, IL). They were then vacuum-dried before being exposed 
to X-ray films (Kodak) for autoradiography. 
TGF-a Radioimmunoassay 
A sensitive radioimmunoassay for rat TGF-a (Russell et al., 1993) was used 
to measure levels of immunoreactive TGF-a in conditioned media as well 
as cell lysates from CID-9 cells, primary mammary epithelial cell cultures 
and glands. Cell and gland lysates were prepared as previously described 
(Sympson et al., 1994), and gland lysates were quantified by Bradford assay. 
A  polyclonal  sheep antiserum  was  raised against  synthetic rat  TGF-a 
(Peninsula Laboratories); the latter was 125I-labeled and used as the stan- 
dard tracer for the assay.  In previous dose-response curves, it was deter- 
mined that mouse-derived TGF-a immunoreactivity was parallel to that of 
the rat TGF-ot standard in the RIA (Russell et al., 1993).  Levels of mouse 
TGF-c~ were therefore expressed in equivalent units of rat TGF-~ standard. 
Results 
ECM and a Three-Dimensional Structure 
Regulate TGF-a Production and Secretion  in 
Mammary Epithelial Cells 
TGF-c¢ has been shown to be expressed in mouse mammary 
gland during certain developmental stages,  and the mito- 
genie activity of this growth factor has been implicated in 
mammary gland ductal morphogenesis (Vonderhaar, 1987; 
Snedeker et al.,  1991).  We examined the possibility that 
TGF-ot regulation may be connected to WAP regulation in 
culture.  Primary mammary  epithelial  cells  isolated  from 
15-d pregnant mouse mammary glands were cultured either 
on plastic or on EHS in the presence of lactogenic hormones. 
Conditioned media and the cell lysates were subjected to 
TGF-u radioimmunoassay (see Materials and Methods). It 
was found that TGF-a levels in the lysate, as well as in the 
conditioned medium of cells cultured on plastic, were sub- 
stantially higher than those of cells cultured on EHS matrix 
(Fig.  1 A). We therefore examined the regulation of TGF-a 
in CID-9 cells cultured on various substrata including EHS, 
floating collagen gel, attached collagen gel and plastic, using 
radioimmunoassay. It was found that the level of TGF-a was 
suppressed only when cells were cultured on EHS, and only 
when three-dimensional spheres were formed (Fig. 1 B). In 
all other culture conditions, plastic, attached collagen, and 
even floating collagen, high levels of TGF-u were found, 
with the level on plastic being the highest. Thus downregula- 
tion of TGF-o~  by ECM, indeed parallels WAP expression in 
culture, and is dependent on formation of three-dimensional 
structures. 
To examine the molecular forms of TGF-a protein, we im- 
munoprecipitated the conditioned medium of primary cells 
cultured either on EHS or on plastic with a polyclonal sheep 
antiserum against synthetic rat TGF-a. Two major proteins 
with apparent molecular mass of 20 kD and 43 kD  were 
precipitated from plastic-conditioned medium but not EHS- 
conditioned medium (Fig.  1 C). Since the most commonly 
secreted form of TGF-o~ is a 5.6-kD peptide, we verified the 
specificity of these proteins by their ability to compete with 
recombinant rat  TGF-ot  for binding  to  the  antibody.  We 
found that the two proteins were no longer immunoprecipi- 
tated when the antibody had been preabsorbed with exces- 
sive amount of recombinant rat TGF-ot, indicating the pres- 
ence of a TGF-ot specific epitope on the two proteins. 
Exogenous TGF-a Inhibits WAP Expression in 
Cells Cultured on EHS 
The demonstration that TGF-a level in PMME cells is in- 
versely proportional to the WAP expression suggested that 
TGF-c~ may  be  a  potential  WAP  inhibitor.  Recombinant 
TGF-c~ was added to cultures where PMME cells had al- 
ready formed alveolar structures on EHS. Under these cul- 
ture conditions, the growth factors present in the EHS prepa- 
rations had no measurable effect on WAP expression since 
"factor-free"  EHS, (Taub et al., 1990) did not induce a higher 
level of WAP expression in cells on EHS (data not shown). 
While both/~-casein and WAP mRNA levels were found to 
be reduced by the presence of the exogenous growth factor, 
inhibition of WAP expression was much more dramatic (Fig. 
2 A).  When a TGF-o~-binding antibody (Bringman et al., 
1987) was incubated with the recombinant growth factor be- 
fore it was added into the culture medium, WAP mRNA level 
was somewhat restored. A monoclonal antibody against hu- 
man growth hormone, treated as above, did not restore WAP 
mRNA levels, confirming that the inhibition of WAP expres- 
sion was specifically due to TGF-c~. The effect of different 
concentrations of TGF-o~ on the levels of WAP protein was 
subsequently examined by immunoprecipitation of WAP pro- 
tein in the cell lysates (Fig. 2 B). WAP protein (a 14-kD ma- 
Lin et al.  TGF-ct Inhibits  WAP Expression  1117 Figure I. T(3F-, activity in the lysates and conditioned media of mammary 
epithelial cells are modulated by culture substrata. (A) TGF-¢ radioimmuno- 
assay of  lysates and conditioned media from primary cultures. Cells were cul- 
tured in differentiation medium. 48-h-conditioned media were collected, and 
cells were lysed. TGF-~ radioimmunoassay was performed as described in 
Materials and Methods. TGF-c~  concentrations in the lysates were expressed 
as the amount of purified rat TGF-c~  bivdin~ that was competed by the lysates. 
Contributions from the culture medium, lysis buffer,  and EHS substratum 
were subtracted from the corresponding values. For primary cultures, the cell 
numbers at the end of the culturing on EHS and plastic conditions were ap- 
proximately the same. Therefore, TGF-cx concentrations in pg/ml could be 
directly compared among different conditions. This bar graph is an average 
of duplicate plates from a typical experiment. (B) T(3F-,~ radioimmunoassay 
of cell lysates from CID-9 cells cultured for 6 d on various culture substrata: 
EHS, floating collagen gel (FG), attached type I collagen gel (Col), and plas- 
tic (PL). Each bar represents the average plus SD for TGF-c~ concentration 
from three separate cultures with identical conditions. Unlike primary cells, 
CID-9 cells continue to grow in the differentiation medium at various rates 
on different culture substrata during the 6-d culture period. Thus, one extra 
dish for each condition was used to obtain cell numbers at the time of lysate 
preparation. The values depicted in the graph have been normalized to cell 
number. (C) TGF-c~ immunoprecipitation from the conditioned media. Pri- 
mary cells were cultured either on plastic (P) or EHS (E) for 5 d before they 
were labeled with [3SS]methionine for 15 h. Conditioned media were then 
collected, cleared of cell debris, and TGF-c~ immunoprecipitation was per- 
formed with a polyclonal sheep antiserum against rat TGF-ct (see Materials 
and Methods). Immunological specificity of the precipitated proteins was 
confirmed by their ability to compete with purified rat TGF-c~ for binding of 
the antibody competition. 
The Journal of Cell Biology,  Volume 129, 1995  1118 Figure 2.  Expression and synthesis of WAP can be inhibited by exogenous TGF-c~. (A) Northern  analysis for WAP mRNA.  Total RNA 
was obtained  from primary cells cultured on EHS (lanes marked with E) or plastic (P) for 6 d. For the last two days of culturing, 20 
ng/ml of recombinant human TGF-c~ was added to cells on EHS (E+TGF-c0.  A monoclonal antibody against either TGF-c~ (30 t~g/ml; 
E+TGF-c~+anti-TGF-a) or human growth hormone (E+TGF-c~+anti-hGH) was incubated with the recombinant TGF-c~  before they were 
added to the cells. Positions for WAP mRNA (lower  panel) and ribosomal RNAs (upper  panel) are indicated.  (B) Immunopreeipitation 
with WAP antibody. Cells were cultured on either EHS (E) or plastic (P) for 5 d before they were labeled for 15 h with [35S]methionine 
and immunopreeipitated  with a rabbit polyclonal anti-mouse WAP. WAP protein level was reduced upon TGF-a treatment (E+TGF-c~  20 
ng/ml and E+TGF-c~  40 ng/ml). As a control for the antibody, the same amount of lysate from an EHS culture was incubated with preim- 
mune rabbit serum (E, preimmune  control) in place of the WAP antiserum. 
jor form and a 6-kD minor form) levels in PMME cells cul- 
tured on EHS were decreased as a  function of increasing 
amounts of TGF-ot added to the medium. The maximum in- 
hibition was achieved with addition of 20 ng/ml of TGF-~. 
The band at 25 kD was due to cross-reactivity of the antise- 
rum  to  another  protein,  since  it  was  not  present  in  the 
precipitate brought down by preimmune serum. The size of 
this protein suggested it could be ~x-casein.  In a separate ex- 
periment testing whether other TGF-ot-like growth factors 
could inhibit WAP expression in our three-dimensionai cul- 
ture, EGF (20 ng/ml) was found to also inhibit WAP expres- 
sion in cells cultured on EHS (data not shown),  indicating 
that EGF receptor was present and most probably involved 
in the WAP inhibition pathway. 
TGF-~ Neutralizing Antibody Reduces 
the WAP Inhibitory Activity Found in the 
Plastic-Conditioned Medium 
Previous work in our laboratory had demonstrated that con- 
ditioned media from all monolayer PMME cultures (plastic, 
attached  collagen,  floating  collagen,  air  dried  EHS,  etc.) 
contained diffusible factors that could inhibit WAP expres- 
sion in cells cultured on EHS (Chen and Bissell,  1989). We 
showed above that exogenous TGF-c~, as well as EGE  in- 
hibited  WAP  expression,  and  that  TGF-o~ synthesis  and 
secretion were upregulated in cells cultured on plastic. We 
therefore investigated the possibility that TGF-o~, or proteins 
related  to  TGF-c~,  may be the  putative WAP  inhibitor(s) 
identified previously. Primary cells which had already formed 
alveolar structures  on  EHS  substratum were treated with 
plastic-conditioned medium with or without preincubation 
with anti-rat TGF-o~ antibody (see Materials and Methods). 
While  plastic-conditioned  medium  reduced  WAP  mRNA 
levels in cells cultured on EHS (Fig. 3, lane 2), incubation 
with a TGF-a neutralizing antibody prevented such an inhi- 
bition  (lane  3),  indicating  that  TGF-¢ in  the  conditioned 
medium was most probably responsible for the inhibition of 
WAP.  Due to the nature of our assay for WAP expression, 
we  can  conclude  only qualitatively that  the  WAP mRNA 
level in cells treated with plastic-conditioned medium prein- 
cubated with antiserum against TGF-c~ (Fig.  3,  lane 3)  is 
similar to that in cells on EHS (Fig.  3, lane 1 ). Therefore, 
we cannot rule out the possibility that other minor WAP in- 
hibiting factors may also be produced by these cells when 
they are cultured on a plastic substratum. 
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tioned medium can be reduced by a neutralizing antibody against 
TGF-c~. RNA was extracted from cells cultured for 6 d on the indi- 
cated substrata. On day 4, cells were either fed with fresh medium 
(lane I and lane 5), or with a 48-h conditioned medium from plastic 
cultures (lanes 2-4). In lanes 3 and 4, a polyclonal antibody against 
rat  TGF-tx and preimmune serum,  respectively, were incubated 
with the conditioned medium. 
TGF-a Can Disrupt the Alveolar Sphere 
Formation and Induce DNA Synthesis in PMME Cells 
Cultured on EHS 
Since an intact three-dimensiot~al structure is known to be 
crucial for WAP expression and TGF-a appeared to inhibit 
WAP expression, we asked whether such an inhibition was 
via disruption of the alveolar structures  formed on EHS. 
TGF-ct (40 ng/ml) was added to the cells once the 3D struc- 
tures were formed (Fig. 4, A-D). After 48 h of incubation 
with TGF-c~, •35  % of the structures had collapsed and were 
visibly disintegrated to differing degrees. In addition, cells 
which migrated out had  incorporated thymidine, whereas 
cells  still  remaining  in  the  spherical  structures  or  their 
peripheries were not. It is worth noting that in the condition 
where no growth factor was added exogenously, even small 
cell  clusters  (with  three or  four cells)  were  negative for 
thymidine incorporation (arrow in 4 A). This indicates that 
TGF-c~ initially disrupted cell-cell interactions necessary for 
the alveolar structures, and then stimulated DNA synthesis 
in those cells which were no longer associated with these 
structures. 
TGF-a Protein Levels and Molecular Forms Are 
Regulated during Pregnancy 
We now have confirmed that the WAP promoter is active in 
virgin and early pregnant mammary glands (Sympson et al., 
1994), yet the WAP messenger RNA is detected only after 
15 d of pregnancy. Since we have demonstrated that TGF-c~ 
and its related proteins inhibit WAP expression in culture, 
the possibility of TGF-o~ being responsible for the delay in 
WAP temporal expression was examined. TGF-~ radioim- 
munoassay indicated a drop ('~50%) in TGF-~ immunoreac- 
tivity in late pregnancy (57 pg/mg protein lysate; calculated 
from the average of two experiments) compared to virgin 
gland and early pregnancy (96 and 104 pg/mg protein lysate, 
respectively). TGF-oe  immunoprecipitation using lysates from 
metabolically labeled 8-d or 15-d glands from pregnant ani- 
mals were more dramatic (Fig. 5). A 14.3-kD TGF-tx protein 
was precipitated from the gland of 8-d pregnant mice, but the 
band disappeared in the 15-d pregnant animal.  The size of 
the precipitated protein suggested that it might be a different 
glycosylation form of the 5.6-kD TGF-ct protein (Dart et al., 
1985; Ignotz et al.,  1986) as previously suggested by Bring- 
man et al. (1987).  We therefore suggest that the loss of the 
14.3-kD TGF-tx protein and the reduction in TGF-tx level, 
measured by the radioimmunoassay in the pregnant animal 
(day 15 or later) could provide at least part of  the explanation 
for the appearance of WAP in late pregnancy. 
Expression  of WAP and B-Casein in Mammary 
Glands from MMTV-TGF-~ Transgenic Mice Are 
Downregulated during Pregnancy 
and Lactation 
If  TGF-c~ inhibits WAP expression in vivo, then TGF-~ trans- 
genic  mice should  show  a  preferential reduction in  WAP 
levels  compared  to  H-casein.  We  took  advantage  of the 
MMTV-TGF-c~ transgenic mice, which had been constructed 
previously (Matsui et al., 1990). It had been shown that over- 
expression of TGF-c~, targeted to the mammary gland by 
MMTV promoter, caused alveolar and terminal ductal hyper- 
plasia in female mice. Northern analysis of total RNA iso- 
lated from transgenic mouse glands of various developmen- 
tal stages (Fig.  6)  showed a  significant reduction of WAP 
mRNA level in the mid-pregnant transgenic mammary gland 
compared with the normal,  nontransgenic gland ('~5 % of 
the normal levels based on densitometry readings of the au- 
toradiographs). An even more dramatic reduction was found 
in the glands of the lactating transgenic animals (as little as 
2 % of the normal levels). The inhibition of/~-casein expres- 
sion by TGF-c¢ overexpression, while substantial,  was less 
profound; H-casein mRNA was reduced to 50% in the gland 
of the pregnant mice, but more severely in the gland of the 
lactating mice (7 % of normal). The inhibition of milk pro- 
tein production in the mammary glands of TGF-c~ transgenic 
mice was confirmed further by immunohistochemistry of  the 
tissue sections from the gland, using antibodies against WAP 
or/3-casein. We found that while both WAP and H-casein 
proteins were much less prevalent in the glands from mid- 
pregnant transgenic mouse than the normal mouse of the 
same stage; the reduction of WAP level was more dramatic 
than that of/~-casein (data not shown). In the transgenic line 
from which we obtained the tissue sections, less than 15 % 
of the alveoli in a gland from a pregnant animal were stained 
positive for WAP, compared with more than 80% in a gland 
from a normal animal, and the level of staining was down 
to the margin of  detection in the gland of  the transgenic mice. 
Additionally, it was difficult to visualize the staining because 
of the disrupted morphology of the gland: compared to the 
normal gland, the alveoli were in general much smaller with 
shrunken central lumina surrounded by multi-layers of epi- 
thelial cells (picture not shown).  Even the low amount of 
milk proteins produced were not properly secreted into the 
lumen as a result of the disorganized gland structure. 
Since we found that inhibition of H-casein expression by 
The Journal of Cell Biology,  Volume 129, 1995  1120 Figure 4.  Disruption of the spherical structures by the addition of TGF-c~. (A) Mammary epithelial cells were cultured on EHS for 6 d. 
[3H]Thymidine was included in the medium during the last 24 h of culturing. Notice that the alveolar structures are uniformly intact and 
no thymidine incorporation is observed even in small clusters (arrow). (B-D).  After 4  d  of culturing on EHS, 40 ng/ml of TGF-ot was 
added to the cell for another 2 d.  In addition,  [3H]thymidine was included in the culture medium for the last 24 h.  Notice that alveolar 
structures were partially destroyed and DNA synthesis was triggered. (B) An area where the effect of TGF-c~ was severe. The arrows show 
the ghosts of alveolar structures.  (C and D) Two different areas representative of a culture after TGF-ot treatment.  The cluster on the top 
part of (D) is a sphere that is beginning to be affected by TGF-c¢. Notice the two cells on the periphery of the sphere which are positively 
labeled for thymidine incorporation.  Bars:  (A) 0.1  mm;  (B) 0.1  mm;  (C) 0.1  mm;  (D) 0.05  mm. 
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glands. Mammary glands from two different sets of 8-d, or 15-d 
pregnant CD-1 mice were labeled with [35S]methionine  for 5 h be- 
fore the tissues were homogenized and immunoprecipitated with 
sheep polyclonal anti-rat TGF-c~  antibody. The positions of  the mo- 
lecular mass markers and the 14.3-kD TGF-c~  band are indicated. 
TGF-a in tissue culture was  not nearly as pronounced as 
WAP, the strong inhibition of t-casein in the glands of the 
transgenic mouse appeared surprising. It is quite likely that 
abnormally high levels of TGF-ot in the transgenic mice, es- 
pecially during lactation, could induce the synthesis of fac- 
tors such as TGF-~, which in turn could inhibit t-casein. 
Discussion 
The establishment of culture conditions which allow mam- 
mary epithelial cells to form three-dimensional structures 
with close resemblance to alveoli in  lactating glands  has 
made it possible to address the important question of how 
tissue  structure  may  influence  functional  differentiation. 
Since whey acidic protein is not expressed by monolayer cul- 
tures (Chen and Bissell,  1989), the nature of the regulation 
by the alveolar structures must be considered in studying the 
regulation of this protein. Our studies reported here demon- 
strate  an  intricate  interaction  between  tissue  structure, 
ECM, and growth factors. We show that ECM plays a domi- 
nant role in the regulation of mammary epithelial cell mor- 
phology and differentiation  by downregulation of  growth fac- 
tor activities. However, the dominant effect of ECM can be 
reversed if growth factor concentration is increased inap- 
propriately. Thus, a full functional differentiation is depen- 
dent on a crucial balance between an intact basement mem- 
brane, a low level of growth factor activity and appropriate 
hormones. The importance of interactions between the ECM 
and growth factors in regulating tissue structure and function 
has been studied in a  number of systems: basic fibroblast 
growth factor (bFGF), for example, can either stimulate en- 
dothelial cell growth or promote capillary differentiation de- 
pending on the ECM molecules used to coat the culture dish 
(Ingber and Folkman,  1989); bFGF signaling in Swiss 3T3 
cells and  MM14  myoblasts were shown  to be modulated 
by heparan  sulfate proteoglycan (Rapraeger et al.,  1991). 
Growth factors were shown to be actively involved in the 
ECM  regulation of morphogenic differentiation of a  sym- 
pathetic neuronal cell line (Rogelj et al.,  1989), and of cul- 
tured baby mouse kidney cells (Tanb et al., 1990). Synthesis 
of ECM proteins were shown to be modulated by growth 
factors,  such as TGF-/~s (Roberts et al.,  1990;  Massague, 
1990), which in turn are regulated by an organized basement 
membrane (Streuli et al.,  1993). Since a change in growth 
factor levels could be a much more rapid process than reor- 
ganization of the basement membrane, the dynamic interac- 
tions between ECM and growth factors could be an impor- 
tant  fine  tuning  mechanism  for  tissue  function  in  vivo. 
Nevertheless, a report by Ferguson et al. (1992) has demon- 
strated surprisingly, cyclical changes in the composition of 
BM in human breast throughout the menstrual cycle. It is 
therefore likely that the hormonal changes during the men- 
strual cycle are accompanied with changes in both growth 
factor activities and the composition of basement membrane 
which in turn would result in changes in the functional status 
of the gland. 
TGF-~ and Proteins Immunologically Related 
to TGF-~ Produced by Mammary Epithelial Cells 
Expression of TGF-ot in adult animals has been documented 
in  several  tissues  such  as  pituitary  gland  (Kobrin et  al., 
1986),  brain  (Wilcox and  Derynck,  1988),  keratinocytes 
Figure  6.  Milk  protein  gene  expression  is  downregulated  in 
MMTV-TGF-a transgenic mice during pregnancy and lactation. 
Northern  analyses were performed with equal amounts of total 
RNA, (3/~g per lane; equal loading confirmed by ethidium bromide 
staining of the 18s and 28s ribosomal RNAs in the gel before trans- 
ferring to the nylon filter), isolated from mammary glands of nor- 
mal (non-TG) or MMTV-TGF-c~  transgenic mice (TG) at various 
developmental stages: (V, virgin; P, 18-d pregnancy; L, 2-d lacta- 
tion). Two different strains of normal mice (C57 black and CD-1 ) 
were compared with the transgenic mice made in a C57 black back- 
ground. Positions of/~-casein and WAP mRNAs are indicated. We 
selected autoradiograms where the intensity of WAP and/~-casein 
bands in the TG lanes are comparable. Thus the degree of inhibition 
can be directly visualized by comparison to the control lanes. 
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14-d  pregnant  mouse  mammary gland  (Snedeker  et  al., 
1991). The molecular form and localization of the TGF-a 
gene product, however, have been overlooked in the past. It 
is  known that TGF-a  is  synthesized as  a  59-amino acid 
precursor transmembrane protein, processed by proteolytic 
cleavage into secreted proteins (for review,  see Derynck, 
1988). Size heterogeneity in both the precursor form and the 
secreted form is an important feature of this polypeptide 
since the precursor protein has a number of N- and O-gly- 
cosylation sites, and the sites for proteolytic cleavage can 
vary. Secreted proteins with molecular masses ranging from 
5-20 kD have been reported (Derynck, 1988).  In addition, 
various forms of TGF-ot protein, including the unprocessed 
pro-form,  have been found to be biologically active (De- 
Larco and Todaro,  1978; Todaro et al., 1980; Brachmann et 
al.,  1989; Wong et al.,  1989;  Luetteke and Lee, 1990).  In 
one report, a  14.3-kD protein, together with the common 
5.6-kD secreted form of  TGF-ot, was precipitated by a TGF-o~ 
antiserum in mouse macrophages (Luetteke et al.,  1993). 
Another report by Alexander et al. (1993) showed that im- 
munoprecipitation with an antibody against TGF-ct, precipi- 
tated three proteins with molecular masses of 5.5 kD, 14.2 
kD, and 20 kD from conditioned media of rat mammary ade- 
nocarcinoma cell cultures. We now have demonstrated that 
a protein "014 kD is produced in the mammary gland of 8-d 
pregnant mice, but no longer produced in the late-pregnant 
(15 D) glands. In addition, we have identified two proteins 
secreted by primary mammary epithelial cells cultured on 
plastic; both can compete with purified rat TGF-ot for the 
binding of a TGF-ot antibody. One of these two proteins has 
an apparent molecular mass of 20 kD, which could be the 
unprocessed precursor form of TGF-tx; the other protein has 
a much larger molecular mass (,043 kD), and therefore is un- 
likely to be a TGF-ot precursor. Conceivably, the 43-kD pro- 
tein could have an epitope recognizable by the anti-TGF-tx 
antibody. The exact identity of this protein remains to be de- 
termined. The difference between the size of TGF-tx immu- 
noprecipitated in culture and in the gland could be due to 
differences in posttranslational processing, such as glycosy- 
lation of the precursor in vivo and in culture. 
ECM Regulates WAP Expression Via Modulating 
TG  F-ot Activity 
We have demonstrated that TGF-c~, or proteins that are im- 
munologically related to TGF-c~, are major components of 
the postulated WAP  inhibitors (Chen and Bissell,  1989). 
These results, together with the results on the role of'I'GF-~l 
in B-casein gene expression (Streuli et al., 1993; also see our 
results on TGF-oL  production in culture), demonstrate a se- 
quential regulation of growth and differentiation by ECM- 
induced modulation of growth factor activities. For/3-casein 
expression, the presence of a basement membrane on float- 
ing collagen gel (Streuli and Bissell,  1990)  is sufficient to 
downregulate  TGF-B1 activity  leading  to  induction  of 
B-casein  expression.  Downregulation  of TGF-a  activity, 
however, requires not only the presence of a basement mem- 
brane, but also a proper three-dimensional structure. Since 
TGF-u and TGF-B have been found to have very different 
properties particularly in their signaling pathways (Shum et 
al., 1994; Wrana et al., 1992) and their mitogenic effects on 
epithelial cells (Vonderhaar,  1987; Coffey  et al., 1988; Mead 
and Fausto, 1989; Ryan et al., 1994), it is not surprising that 
the  two factors have distinct functions and are  regulated 
differently in mammary epithelial cells. 
WAP expression in culture depends more on the presence 
of hydrocortisone than on prolactin, another important differ- 
ence between WAP and B-casein  expression (Pittius et 8.1., 
1988b).  Hydrocortisone has been shown to induce the fight 
junction formation in a murine manamary cell line of ductal 
origin (Zettl et al,  1992).  A rat mammary adenocarcinoma 
cell line has been shown to lose the ability to form tight  junc- 
tions in the presence of glucocorticoid when it is transfected 
with a TGF-o~ expression vector (Firestone and Buse, 1994). 
It is therefore possible that the hydrocortisone requirement 
for WAP expression reflects a need for tight junctions which 
are necessary for maintaining alveolar structures with pola- 
rized lumina. We propose that TGF-ot may interfere with cell- 
cell interaction and consequently three-dimensional struc- 
tures, by affecting the integrity of the junctional complexes. 
Possible Link between the Change in 
TGF-~ Activity during Pregnancy and the Differential 
Temporal Regulation of  Milk Protein Expression 
TGF-o~ inhibits both B-casein and WAP; however, the latter 
is much more affected by this growth factor both in culture 
and in transgenic mice. This differential regulation may ac- 
count for the long-standing observation that WAP is ex- 
pressed in pregnant mice later in gestation than is B-casein 
(Pittius,  1988a,b).  Snedeker et al.  (1991) have shown that 
TGF-~ mRNA is detectable in mature virgin or 14-d preg- 
nant gland but undetectable in premature virgin, or  10-d 
lactating gland. Since TGF-a is known to undergo posttran- 
scriptional modifications (DeLarco and Todaro, 1978; Todaro 
et al, 1980;  Massague, 1990),  both the level of the protein 
and its receptor binding need to be considered in addition 
to mRNA levels. We now have shown that the level of TGF-tx, 
measured by radioimmunoassay, as well as the profile of 
TGF-tx immunoprecipitable proteins,  change as the preg- 
nancy proceeds. There is a correlation between the decrease 
in total TGF-~ immunoreactivity and the disappearance of 
a  14.3-kD  TGF-c~ immunoprecipitable protein as the gland 
enters late pregnancy. Therefore, the drop in TGF-~ activity 
coincides with WAP expression in the gland. Since TGF-c~ 
is known to bind to EGF receptor in order to exert its biolog- 
ical function, the level of EGF receptor also needs to be con- 
sidered. EGF receptor level has been shown previously to 
increase in the beginning of preguancy (FAery et al., 1985), 
reaching the highest level  by day 10.  Taking into account 
changes of both protein and receptor levels from early (be- 
fore day-10) to late- (after day-15) pregnancy, we propose that 
TGF-a is a physiologically relevant regulator of WAP gene 
expression. It is possible that WAP expression in late preg- 
nancy and lactating stages is not only due to downregulation 
of TGF-a production, but also to decreased levels of the 
receptor for TGF-a. EGF has previously been demonstrated 
to be a mitogen for manunary epithelial cells (V0nderhaar, 
1987).  However, both EGF mRNA and the EGF precursor 
protein have been shown to be present in all stages of mam- 
mary gland development including lactation (Brown et al., 
1989;  Snedeker et al.,  1991). This indicates that EGF has 
a  very different function in the lactating mammary gland 
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for milk EGF in the development of the gastrointestinal tract 
and perhaps other organs of the neonate. 
A Possible Mechanism for Downregulation of 
TGF-a as a Result of  Formation of Three-Dimensional 
Alveolar Structures 
TGF-c~ has been shown to be an autocrine growth factor in- 
volved in the control of normal and malignant cell growth in 
various  systems including human keratinocytes (Coffey et 
al.,  1988; Vassar and Fuchs, 1991), hepatocytes (Mead and 
Fausto,  1989), colorectal epithelial cells (Untawale et al., 
1993), mammary epithelial cells (see Ciardiello et al., 1991 
for review), and rat tracheal epithelial cells (Ferriola et al., 
1992). In addition, autoinduction of TGF-c~ expression has 
been documented as a novel mechanism of autoregulation of 
cell growth  (Coffey et al.,  1987,  1992;  Untawale  et  al., 
1993). We have shown here that TGF-c~ expression is sup- 
pressed in mouse mammary epithelial cultures only when 
both a basement membrane and an alveolar structure are 
present. Since cells cultivated on EHS respond to exogenous 
TGF-ot, there must be receptors on the basolateral surface of 
the cells in the alveolar structures. The preferential basola- 
teral localization of EGF receptor in epithelial cells have pre- 
viously been demonstrated in other epithelial cell systems 
such as human gastric mucosa (Orsini et al., 1993), and hu- 
man breast cancer cells (Monaghan et al.,  1990; for review 
see Fukuyama and Shimizu,  1991).  Snedecker et al. (1991) 
have immunolocalized EGF to the luminal surface of ductal 
epithelium during  mammary  gland ductal  morphogenesis 
(Snedecker et al.,  1991). This group has demonstrated that 
the differentiated alveolar epithelium in the lactating mam- 
mary gland can synthesize EGF precursor and have found 
that abundant levels of EGF are detected in milk (Brown et 
al.,  1989). Thus EGF poses no threat to differentiation or 
WAP expression in pregnant and lactating mammary gland 
presumably because it is secreted apically and does not inter- 
act with the basolateral EGF receptor. In contrast, TGF-c~ 
was localized to the basal cap-cell layer in the developing rat 
mammary gland (Snedecker et al.,  1991) and one of our 
laboratories has demonstrated lateral TGF-ct staining within 
the  ductal  mammary  epithelium of MMTV-TGF-a trans- 
genic mice (Matsui et al.,  1990; Dempsey, P. J., and R. J. 
Coffey, unpublished results). In addition, we have shown re- 
cently  that  pro-TGF-a  is  targeted  preferentially  to  the 
basolateral surface of polarized epithelial cells and can act 
in an autocrine manner (Dempsey and Coffey,  1994). Fur- 
thermore, we have found in vitro differences in growth factor 
production,  consumption  and  response  as  well  as  EGF 
receptor recycling in epithelial cells when grown as a pola- 
rized monolayer on transwell  filters as compared to cells 
grown on plastic (Dempsey, P.  J.,  H.  S.  Wiley, and R.  J. 
Coffey, unpublished results). These findings suggest that the 
polarized state and the three dimensional architecture of the 
mammary  epithelium observed in  vitro and  in  vivo may 
influence the production and routing of TGF-ct and conse- 
quent signaling through the EGF receptor. Additional com- 
plexity ensues from the secretory nature of  the mammary ep- 
ithelium and warrants further investigation. 
Components in the microenvironment of a cell normally 
include the neighboring cells, the ECM, the tissue- and de- 
velopmental stage-specific hormones, and the locally acting 
growth factors. The fate of a cell within a tissue is deter- 
mined by the net result of interactions among these compo- 
nents, and the structure and function of a tissue therefore is 
ultimately dependent on its  immediate microenvironment 
(Stoker et al., 1990). These studies provide a striking exam- 
ple of how the tissue structure and functional differentiation 
in mammary epithelium are controlled by the concerted ac- 
tion of ECM, neighboring cells, hormones, and growth fac- 
tors in the microenvironment of the breast tissue. 
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